February, 2019 - MJZanon IP Attorney - Expert Patent & Trademark Lawyer in Brazil

Regeneron and Sanofi strongly disagree with verdict upholding three of five Amgen U.S. patent claims relating to PCSK9 antibodies

Monday, February 25, 2019 DrugName : alirocumab Regeneron Pharmaceuticals, Inc., and Sanofi announced they strongly disagree with certain aspects

Aurinia receives notice of allowance from the US Patent and Trademark Office for claims directed to its novel voclosporin dosing protocol for lupus nephritis

Monday, February 25, 2019 | Sentiment: Positive | DrugName : voclosporin Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company

FDA issues 74 product-specific guidances to help promote generic drug access and drug competition

Friday, February 22, 2019 The U.S. Food and Drug Administration announced a new set of product-specific guidances to support industry

Optinose announces issuance of four additional U.S. patents covering XHANCE

Tuesday, February 19, 2019 Precautionary measures: Utilization of Sildenafil Citrate is not a generic version of rx tadalafil. The impact

Innovation Pharmaceuticals receives new patent for compounds for use in treatment of Oral Mucositis

Tuesday, February 19, 2019 The tablets are prepared with a chemical PDE-5 inhibitor. viagra viagra buy At the same time,